3,5-Dichloropyridazine
Grundinformationen
- CAS
1837-55-4- Standard-SMILES
Clc1cnnc(Cl)c1- InChIKey
JZSAUQMXKHBZEO-UHFFFAOYSA-N- Summenformel
- C4H2Cl2N2
- Durchschnittliche Molmasse
- 148,98 g/mol
- Monoisotopische Masse
- 147,9595035
Namen und Bezeichner
- Bevorzugter Name
- 3,5-Dichloropyridazine
- IUPAC
- 3,5-dichloropyridazine
- Englischer Name
- 3,5-Dichloropyridazine
- Summenformel
- C4H2Cl2N2
- Molmasse
- 148.98
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
1837-55-4- PubChem CID
- 19959687
- DTXSID
DTXSID20601477- ChEBI
CHEBI:194771- UNII
- 74Q8S45BRC
- EC Number
- 692-072-0
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 1,4
- Polarare Oberfläche (TPSA)
- 25,8 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 8
- Formalladung
- 0
- Komplexität
- 78
Physikochemische Eigenschaften
- Schmelzpunkt
- 60 to · 60.0 to 64.0 °C
- Siedepunkt
- 280.8 · 280.8±20.0 °C(Predicted)
- Dichte
- 1.493 · 1.493±0.06 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Sealed in dry,Room Temperature
- Löslichkeit
- DMSO (Sparingly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- -0.25 · -0.25±0.10(Predicted)
- Farbe
- Yellow to Dark Orange
- InChI
- InChI=1S/C4H2Cl2N2/c5-3-1-4(6)8-7-2-3/h1-2H
- InChIKey
- JZSAUQMXKHBZEO-UHFFFAOYSA-N
- SMILES
- C1(Cl)=NN=CC(Cl)=C1
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302+H312+H332 (82.4%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation];H302 (97.1%): Harmful if swallowed [Warning Acute toxicity, oral];H312 (88.2%): Harmful in contact with skin [Warning Acute toxicity, dermal];H315 (97.1%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (97.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H332 (88.2%): Harmful if inhaled [Warning Acute toxicity, inhalation];H335 (94.1%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 34 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Sicherheitsdaten
- wgk
- WGK 3
- hs_code
- 29339900
- risk_code
- 22
- hazard_code
- Xn
- Speicherklasse
- 11 - Combustible Solids
- Hazard Classifications
- Acute Tox. 4 Oral
Chemie und Industrie
Anwendungen
Verwenden3,5-Dichloropyridazine used in the treatment of asthma and allergy. Potential for antinociceptive and antiinflammatory effects
Darstellung
synthetischePreparation of 3,5-Dichloropyridazine:2,4,4,4-Tetrachlorocrotonaldehyde is dissolved in a solvent, and a mixture of semicarbazide hydrochloride, water, and solvent is added dropwise under controlled temperature conditions. The reaction is stirred for 5 hours. Afterward, the reaction mixture is concentrated under reduced pressure to remove the solvent. Water is added, and the temperature is lowered to 5°C, allowing a solid to precipitate. The solid is filtered and recrystallized using a dichloromethane/petroleum ether mixture, yielding 3,5-dichloropyridazine as a white crystalline solid.
Vor- und nachgelagerte Produkte
Nachgelagerte Produkte
Anbieter100 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…